Focus: Perimeter Medical Imaging AI is a Toronto-based biotech company specializing in AI-driven cancer surgical margin identification technology for oncology applications. The company operates in a niche medical device/AI space focused on improving surgical precision.
Profile data last refreshed 10h ago · AI intelligence enriched 2w ago
Best fit for early-stage biotech operators who thrive in uncertainty and want meaningful oncology impact; avoid if you require financial transparency or established product-market fit.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Perimeter Medical Imaging AI
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Perimeter Medical Imaging AI's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo